NEW
YORK, May 24, 2023 /PRNewswire/ -- The Gross Law
Firm issues the following notice to shareholders of NRx
Pharmaceuticals Inc. (f/k/a Big Rock Partners Acquisition
Corp.) (NASDAQ: NRXP)
The Gross Law Firm has commenced an investigation into the
fairness of NRx Pharmaceuticals Inc.'s De-SPAC Merger. Shortly
after the NRXP 2021 de-SPAC merger closed, NRXP stock began
spiraling downwards. The NRXP de-SPAC merger investigation concerns
whether this transaction unfairly harmed stockholders and whether
all material facts were properly disclosed to stockholders.
NRX PHARMACEUTICALS SHAREHOLDERS SHOULD CONTACT US HERE:
https://securitiesclasslaw.com/mna/nrx-pharmaceuticals-information-request-form/
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law Firm is
committed to ensuring that companies adhere to responsible business
practices and engage in good corporate citizenship. The firm seeks
recovery on behalf of investors who incurred losses when false
and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-an-investigation-into-the-fairness-of-nrx-pharmaceuticals-incs-de-spac-merger-301830356.html
SOURCE The Gross Law Firm